Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β-catenin/N-cadherin axis

The phosphorylation of pyruvate dehydrogenase (PDH) by pyruvate dehydrogenase kinase (PDK) 4 inhibits its ability to induce a glycolytic shift. PDK4 expression is upregulated in various types of human cancer. Because PDK4 regulation is critical for metabolic changes in cancer cells, it is an attract...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chul Jang, Terado, Tokio, Tambe, Yukihiro, Mukaisho, Ken-Ichi, Kageyama, Susumu, Kawauchi, Akihiro, Inoue, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131085/
https://www.ncbi.nlm.nih.gov/pubmed/33982789
http://dx.doi.org/10.3892/ijo.2021.5220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131085/
https://www.ncbi.nlm.nih.gov/pubmed/33982789
http://dx.doi.org/10.3892/ijo.2021.5220

Ejemplares similares